We are live on ! Find out more
CAM

Cresset Asset Management Portfolio holdings

AUM $23.1B
1-Year Est. Return 27.04%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
AUM
$7.06B
AUM Growth
+$739M
Cap. Flow
+$195M
Cap. Flow %
2.76%
Top 10 Hldgs %
64.54%
Holding
1,102
New
171
Increased
503
Reduced
296
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 40.17%
2 Consumer Discretionary 6.79%
3 Healthcare 3.61%
4 Financials 3.09%
5 Communication Services 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLKB icon
1026
Blackbaud
BLKB
$2.08B
-4,443
Closed -$317K
CAG icon
1027
Conagra Brands
CAG
$7.23B
-5,943
Closed -$223K
CCL icon
1028
Carnival Corporation Ltd
CCL
$39.7B
-7,785
Closed -$207K
CGEN icon
1029
Compugen
CGEN
$228M
-29,400
Closed -$252K
CSTL icon
1030
Castle Biosciences
CSTL
$979M
-4,047
Closed -$277K
DINO icon
1031
HF Sinclair
DINO
$14.5B
-5,752
Closed -$206K
DOC icon
1032
Healthpeak Properties
DOC
$14.8B
-7,556
Closed -$239K
EBS icon
1033
Emergent Biosolutions
EBS
$248M
-2,478
Closed -$231K
EHI
1034
Western Asset Global High Income Fund
EHI
$178M
-12,000
Closed -$127K
EMN icon
1035
Eastman Chemical
EMN
$8.42B
-2,107
Closed -$233K
ETV
1036
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.76B
-59,902
Closed -$928K
FATE icon
1037
Fate Therapeutics
FATE
$326M
-6,200
Closed -$510K
FSK icon
1038
FS KKR Capital
FSK
$3.44B
-11,599
Closed -$236K
G icon
1039
Genpact
G
$5.81B
-6,333
Closed -$271K
GBDC icon
1040
Golub Capital BDC
GBDC
$3.42B
-13,044
Closed -$191K
GH icon
1041
Guardant Health
GH
$22.6B
-1,728
Closed -$264K
GSLC icon
1042
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.5B
-3,520
Closed -$278K
HIX
1043
Western Asset High Income Fund II
HIX
$355M
-20,000
Closed -$139K
HYD icon
1044
VanEck High Yield Muni ETF
HYD
$4.45B
-16,793
Closed -$1.04M
INDA icon
1045
iShares MSCI India ETF
INDA
$6.63B
-11,014
Closed -$465K
IONS icon
1046
Ionis Pharmaceuticals
IONS
$9.4B
-5,728
Closed -$258K
ITB icon
1047
iShares US Home Construction ETF
ITB
$2.35B
-4,028
Closed -$273K
IWO icon
1048
iShares Russell 2000 Growth ETF
IWO
$15.1B
-816
Closed -$246K
IYJ icon
1049
iShares US Industrials ETF
IYJ
$2.02B
-3,445
Closed -$364K
IYZ icon
1050
iShares US Telecommunications ETF
IYZ
$1.26B
-57,367
Closed -$1.85M

Similar funds

Cresset Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Cresset Asset Management held 1,102 positions worth $7.06B, up 12% from $6.32B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Cresset Asset Management's Q2 2021 filing shows 171 new, 503 increased, 296 reduced and 86 closed positions. Its largest new stake was RTX Corp: 183,725 shares worth $15.7M. The largest sale was ARK Innovation ETF, an estimated $68.1M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Cresset Asset Management's largest Q2 2021 buy was RTX Corp: 183,725 shares worth $15.7M.
  • Cresset Asset Management added most to Apple in Q2 2021, an estimated $53M increase.
  • Cresset Asset Management's biggest Q2 2021 reduction was ARK Innovation ETF, cutting an estimated $68.1M.
  • Cresset Asset Management fully exited iShares MSCI USA Value Factor ETF in Q2 2021, selling an estimated $20.3M.
  • Cresset Asset Management's ten largest holdings make up 65% of its $7.06B portfolio in Q2 2021.
  • Cresset Asset Management opened 171 new positions and closed 86 in Q2 2021.
  • Cresset Asset Management's portfolio value rose 12% quarter-over-quarter to $7.06B.

Based on Cresset Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.